iShares Biotechnology ETF (NASDAQ:IBB) Position Increased by Commerce Bank

Commerce Bank lifted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 1.8% during the third quarter, HoldingsChannel reports. The institutional investor owned 743,366 shares of the financial services provider’s stock after purchasing an additional 12,921 shares during the period. Commerce Bank’s holdings in iShares Biotechnology ETF were worth $108,234,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Avior Wealth Management LLC grew its holdings in shares of iShares Biotechnology ETF by 438.2% during the third quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock valued at $470,000 after purchasing an additional 2,629 shares during the last quarter. Counterweight Ventures LLC boosted its position in iShares Biotechnology ETF by 46.7% during the 3rd quarter. Counterweight Ventures LLC now owns 8,454 shares of the financial services provider’s stock valued at $1,231,000 after purchasing an additional 2,693 shares during the period. Prospera Financial Services Inc grew its stake in iShares Biotechnology ETF by 5.6% during the 3rd quarter. Prospera Financial Services Inc now owns 2,880 shares of the financial services provider’s stock worth $419,000 after buying an additional 152 shares during the last quarter. LMR Partners LLP acquired a new stake in iShares Biotechnology ETF in the third quarter worth $4,904,000. Finally, Thrivent Financial for Lutherans boosted its holdings in shares of iShares Biotechnology ETF by 354.7% during the third quarter. Thrivent Financial for Lutherans now owns 48,476 shares of the financial services provider’s stock valued at $7,058,000 after acquiring an additional 37,814 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $133.39 on Wednesday. The company has a 50-day moving average price of $144.03 and a two-hundred day moving average price of $141.80. iShares Biotechnology ETF has a 52 week low of $117.28 and a 52 week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.